Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Darrow Stem Cell Institute is a Los Angeles regenerative medicine clinic associated with physician Marc Darrow, MD, JD, and focused on non-surgical treatment of orthopedic and pain-related conditions. The practice markets stem cell therapy, platelet-rich plasma therapy, prolotherapy, and related injection-based procedures for joint, spine, tendon, and sports injury indications. Its clinical focus appears to center on musculoskeletal disorders such as knee and hip osteoarthritis, back and neck pain, shoulder disorders, and post-surgical pain. Rather than operating like a drug-development biotech with a disclosed therapeutic pipeline, it functions as a commercial healthcare provider delivering physician-administered regenerative medicine services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Darrow Stem Cell Institute.